Cargando…
Changing incentives to ACCELERATE drug development for paediatric cancer
BACKGROUND: More effective incentives are needed to motivate paediatric oncology drug development, uncoupling it from dependency on adult drug development. Although the current European and North‐American legislations aim to promote drug development for paediatrics and rare diseases, children and ad...
Autores principales: | de Rojas, Teresa, Kearns, Pamela, Blanc, Patricia, Skolnik, Jeffrey, Fox, Elizabeth, Knox, Leona, Rousseau, Raphael, Doz, François, Bird, Nick, Pearson, Andrew J., Vassal, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134303/ https://www.ncbi.nlm.nih.gov/pubmed/36645217 http://dx.doi.org/10.1002/cam4.5627 |
Ejemplares similares
-
Intercontinental collaboration in clinical trials for children and adolescents with cancer—A systematic review by ACCELERATE
por: de Rojas, Teresa, et al.
Publicado: (2021) -
A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours
por: Lowis, S, et al.
Publicado: (2006) -
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
por: Moreno, Lucas, et al.
Publicado: (2023) -
Paediatric palliative home care by general paediatricians: a multimethod study on perceived barriers and incentives
por: Jünger, Saskia, et al.
Publicado: (2010) -
Dose finding and O(6)-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies
por: Geoerger, B, et al.
Publicado: (2005)